Alignment Healthcare (NASDAQ:ALHC) Stock Price Up 8.7% – Here’s What Happened

Alignment Healthcare, Inc. (NASDAQ:ALHC) shares traded up 8.7% on Thursday . The stock traded as high as $21.42 and last traded at $21.78. Approximately 736,824 shares changed hands during trading, a decline of 83% from the average daily volume of 4,405,751 shares. The stock had previously closed at $20.03.

Alignment Healthcare News Summary

Here are the key news stories impacting Alignment Healthcare this week:

• Negative Sentiment: Hagens Berman and other firms are investigating Alignment Healthcare after reports of a whistleblower lawsuit alleging systemic accounting irregularities and financial manipulation, which raised securities-fraud concerns and triggered a sharp selloff. Article Title
• Negative Sentiment: Additional law firms, including Block & Leviton and Johnson Fistel, launched separate investor investigations into ALHC, adding to uncertainty and keeping pressure on the stock. Article Title
• Negative Sentiment: Market commentary said ALHC had its worst day in more than two years on the whistleblower allegation report, underscoring how seriously investors are taking the claims. Article Title
• Neutral Sentiment: Alignment Healthcare said it will report second-quarter 2026 results on July 30, which could provide a clearer view of fundamentals and help determine whether the recent selloff is justified. Article Title
• Positive Sentiment: Separate analyst commentary noted Alignment’s use of AI automation, quality-plan initiatives, and complex-care growth as long-term supports for Medicare Advantage economics, which could help offset some of the headline risk if execution remains strong. Article Title

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on ALHC shares. Wolfe Research started coverage on shares of Alignment Healthcare in a report on Friday, April 17th. They issued an “outperform” rating and a $24.00 price objective for the company. UBS Group reiterated a “neutral” rating on shares of Alignment Healthcare in a research note on Wednesday. Barclays decreased their price target on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. Raymond James Financial set a $22.00 price target on Alignment Healthcare in a report on Thursday, May 7th. Finally, Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday. Six analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average target price of $24.30.

Alignment Healthcare Stock Performance

The company has a market cap of $4.41 billion, a P/E ratio of 237.68, a P/E/G ratio of 3.25 and a beta of 1.05. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 1.56. The business has a fifty day simple moving average of $19.13 and a two-hundred day simple moving average of $19.79.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. During the same period in the previous year, the company posted ($0.05) EPS. The business’s quarterly revenue was up 33.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Alignment Healthcare, Inc. will post 0.2 EPS for the current year.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, insider Hyong Kim sold 35,951 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $19.86, for a total transaction of $713,986.86. Following the completion of the sale, the insider directly owned 331,750 shares of the company’s stock, valued at approximately $6,588,555. This represents a 9.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Mark D. Kent bought 14,848 shares of Alignment Healthcare stock in a transaction on Tuesday, June 2nd. The shares were acquired at an average cost of $13.31 per share, with a total value of $197,626.88. Following the completion of the acquisition, the insider owned 14,848 shares of the company’s stock, valued at $197,626.88. The trade was a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders sold a total of 1,069,951 shares of company stock valued at $20,846,518 in the last three months. Corporate insiders own 5.20% of the company’s stock.

Hedge Funds Weigh In On Alignment Healthcare

Institutional investors have recently bought and sold shares of the stock. Allworth Financial LP lifted its position in Alignment Healthcare by 8.9% during the fourth quarter. Allworth Financial LP now owns 6,917 shares of the company’s stock valued at $137,000 after purchasing an additional 566 shares in the last quarter. State of Alaska Department of Revenue increased its position in Alignment Healthcare by 6.0% in the fourth quarter. State of Alaska Department of Revenue now owns 11,296 shares of the company’s stock worth $223,000 after buying an additional 636 shares in the last quarter. Integrated Wealth Concepts LLC increased its position in Alignment Healthcare by 6.3% in the third quarter. Integrated Wealth Concepts LLC now owns 11,230 shares of the company’s stock worth $196,000 after buying an additional 665 shares in the last quarter. Parallel Advisors LLC raised its stake in shares of Alignment Healthcare by 87.7% in the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after buying an additional 773 shares during the period. Finally, Tidal Investments LLC lifted its position in shares of Alignment Healthcare by 4.9% during the 2nd quarter. Tidal Investments LLC now owns 18,094 shares of the company’s stock valued at $253,000 after buying an additional 852 shares in the last quarter. 86.19% of the stock is owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.